Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accropeutics, Applied Therapeutics, Celltrion, Dyne, Hibio, Janssen, Legend, Pfizer, Sandoz.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Biontech, DMK, Intercept, Madrigal, Pfizer.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annexon, Antabio, Apellis, Bial, Bioinvent, Bioxcel, Harmony, Immutep, Jaguar, Lynk, Onconova, Stallergenes, Stemcyte, Topas, Transgene, Vanda.

Biopharmas raising money in public or private financings, including: Agile, Aptose, Carmot, Effector, Lyra, Tscan, Vivoryon.

New hires and promotions in the biopharma industry, including: Talaris.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cytek Biosciences, Flowmetric, Nox Health, Pear.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biosency, Biospectal, Bonesupport.

Med-tech firms raising money in public or private financings, including: Biocept, Hememics.

New hires and promotions in the med-tech industry, including: Emmes, Illumina.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allos, Astrazeneca, Bioray, Braeburn, Innoviva, Inovio, Phathom, Sarepta, Tryp.